228 related articles for article (PubMed ID: 7549798)
1. Pelvic inflammatory disease and the risk of epithelial ovarian cancer.
Risch HA; Howe GR
Cancer Epidemiol Biomarkers Prev; 1995; 4(5):447-51. PubMed ID: 7549798
[TBL] [Abstract][Full Text] [Related]
2. Pelvic inflammatory disease and risk of ovarian cancer.
Parazzini F; La Vecchia C; Negri E; Moroni S; dal Pino D; Fedele L
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):667-9. PubMed ID: 8824371
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for ovarian cancer in central Italy.
Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
[TBL] [Abstract][Full Text] [Related]
4. Anthropometry and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Ness RB; Allen GO
Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
[TBL] [Abstract][Full Text] [Related]
5. A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs.
Rossing MA; Tang MT; Flagg EW; Weiss LK; Wicklund KG
Am J Epidemiol; 2004 Dec; 160(11):1070-8. PubMed ID: 15561986
[TBL] [Abstract][Full Text] [Related]
6. "Older" age is a risk factor for pelvic inflammatory disease in intrauterine device users.
Viberga I; Odlind V; Berglund L
Acta Obstet Gynecol Scand; 2005 Dec; 84(12):1202-7. PubMed ID: 16305709
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
8. Timing of pregnancy and the risk of epithelial ovarian cancer.
Whiteman DC; Siskind V; Purdie DM; Green AC
Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):42-6. PubMed ID: 12540502
[TBL] [Abstract][Full Text] [Related]
9. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
[TBL] [Abstract][Full Text] [Related]
12. Aspirin and epithelial ovarian cancer.
Akhmedkhanov A; Toniolo P; Zeleniuch-Jacquotte A; Kato I; Koenig KL; Shore RE
Prev Med; 2001 Dec; 33(6):682-7. PubMed ID: 11716667
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk.
Mills PK; Riordan DG; Cress RD; Goldsmith DF
Cancer Detect Prev; 2005; 29(2):124-32. PubMed ID: 15829372
[TBL] [Abstract][Full Text] [Related]
15. Intakes of selected nutrients and food groups and risk of ovarian cancer.
McCann SE; Moysich KB; Mettlin C
Nutr Cancer; 2001; 39(1):19-28. PubMed ID: 11588898
[TBL] [Abstract][Full Text] [Related]
16. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk.
Parazzini F; Negri E; La Vecchia C; Luchini L; Mezzopane R
Obstet Gynecol; 1993 Mar; 81(3):363-6. PubMed ID: 8437787
[TBL] [Abstract][Full Text] [Related]
17. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.
Tworoger SS; Fairfield KM; Colditz GA; Rosner BA; Hankinson SE
Am J Epidemiol; 2007 Oct; 166(8):894-901. PubMed ID: 17656616
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives and epithelial ovarian cancer. Does dose matter?
Sanderson M; Williams MA; Weiss NS; Hendrix NW; Chauhan SP
J Reprod Med; 2000 Sep; 45(9):720-6. PubMed ID: 11027080
[TBL] [Abstract][Full Text] [Related]
19. Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors.
Rasmussen CB; Faber MT; Jensen A; Høgdall E; Høgdall C; Blaakær J; Kjaer SK
Cancer Causes Control; 2013 Jul; 24(7):1459-64. PubMed ID: 23615817
[TBL] [Abstract][Full Text] [Related]
20. Tubal ligation and the risk of ovarian carcinoma.
Cornelison TL; Natarajan N; Piver MS; Mettlin CJ
Cancer Detect Prev; 1997; 21(1):1-6. PubMed ID: 9043756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]